Low and Declining Rate of 4-Class ARV Resistance Among Treatment-Experienced Patients in the EuResist Database

March 8-11, 2020; Boston, Massachusetts
Analysis of the EuResist database reveals prevalence and predictors of resistance to all 4 main ARV drug classes in treatment-experienced patients in Europe.
Format: Microsoft PowerPoint (.ppt)
File Size: 158 KB
Released: March 15, 2020

Acknowledgements

Provided by USF Health, in partnership with Clinical Care Options, LLC

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@usf.edu
https://health.usf.edu/cpd

This activity is supported by educational grants from
Gilead Sciences
ViiV Healthcare

Related Content

Short video log from Jürgen Rockstroh, MD, on treating an older man recently diagnosed with HIV/HBV coinfection

Jürgen K. Rockstroh, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 20, 2020 Expired: October 19, 2021

Download CCO slides reviewing data and guidelines on management of heavily-treatment experienced patients with HIV experiencing treatment failure

Joseph J. Eron, Jr., MD Princy N. Kumar, MD, FIDSA, MACP Released: October 20, 2020

Expert-authored CCO slides on simplification to 2-drug ART, ART safety during pregnancy, ART and weight gain, and long-acting injectable ART

W. David Hardy, MD
Program Director
Michelle S. Cespedes, MD, MS
Released: October 20, 2020

Download free expert-authored slides reviewing a patient case and the relevant data and guidance on HIV/HBV coinfection in older patients

Jürgen K. Rockstroh, MD Released: October 20, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue